Wealthcare Advisory Partners LLC Myriad Genetics Inc Transaction History

Wealthcare Advisory Partners LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$25.39 - $32.61 $30,594 - $39,295	-1,205 Closed	0 $0
Q1 2021 Apr 30, 2021	BUY	$19.92 - $31.6 $24,003 - $38,078	1,205 New	1,205 $37,000
Q2 2020 Jul 29, 2020	SELL	$10.69 - $16.49 $2,191 - $3,380	-205 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$27.75 - $40.17 $2,775 - $4,017	100 Added 95.24%	205 $8,000
Q3 2017 Nov 15, 2017	BUY	$24.01 - $36.2 $2,521 - $3,801	105	105 $4,000

253

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.25B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Wealthcare Advisory Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Wealthcare Advisory Partners LLC with notifications on news.